Direct and indirect costs of asthma to an employer

Slides:

Advertisements

Similar presentations

Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,

Advertisements

Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies Kathrin M. Cresswell, MSc, Aziz Sheikh,

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy Monica B. Arvidsson, MD, Olle.

Pharmacologic rationale for treating allergic and nonallergic rhinitis

Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies Kathrin M. Cresswell, MSc, Aziz Sheikh,

Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,

Rosa Codina, PhD, Richard F. Lockey, MD

Applying epidemiologic concepts of primary, secondary, and tertiary prevention to the elimination of racial disparities in asthma Christine L.M. Joseph,

Practice Notes from the AAAI

Badrul A. Chowdhury, MD, PhD

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma B.Lauren Charous, MD, Elkan F. Halpern,

Inflammation of small airways in asthma

NAEPP Expert Panel Report

Edwin A. Bronsky, MD, Howard Druce, MD, Steven R. Findlay, MD, Frank C

Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis.

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Elephantiasis nostras: A case report

Redefining Appropriate Treatment Expectations

Treatment of chronic autoimmune urticaria with omalizumab

William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P

Practice Notes from the AAAAI

Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA

Reply Journal of Allergy and Clinical Immunology

A review of the current guidelines for allergic rhinitis and asthma

Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation Leif Bjermer, MD Journal of Allergy.

Physician-targeted program on inhaled therapy for childhood asthma

News & Notes Journal of Allergy and Clinical Immunology

Circadian variation of sputum inflammatory cells in mild asthma

Biosimilars and drug development in allergic and immunologic diseases

Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization Qutayba Hamid, MD, PhD, Editor Journal.

Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma Mamert Milewski, MD, Lucyna Mastalerz, MD, Ewa Niżankowska, MD, Andrzej.

Effect of ozone and nitrogen dioxide on the release of proinflammatory mediators from bronchial epithelial cells of nonatopic nonasthmatic subjects and.

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma William.

Molecular virology and immunology of HIV infection

Exercise-induced bronchoconstriction in children: Montelukast attenuates the immediate-phase and late-phase responses Raul E. Melo, MD, Dirceu Solé,

Medication use in children with asthma in Finland from 1995 to 2006

Vascular endothelial growth factor in patients with acute asthma

H. William Kelly, PharmD Journal of Allergy and Clinical Immunology

Personalized asthma therapy in blacks—the role of genetic ancestry

Autophagy: Nobel Prize 2016 and allergy and asthma research

News & Notes Journal of Allergy and Clinical Immunology

Table of contents The Journal for Nurse Practitioners

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

Advances in the approach to the patient with food allergy

Observations on emerging patterns of asthma in our society

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Volume 11, Issue 1, (February 2013)

Inhaled corticosteroids and allergy specialty care reduce emergency hospital use for asthma Michael Schatz, MD, MSa, E.Francis Cook, DScb, Randy Nakahiro,

Intracellular IL-5 and T-lymphocyte subsets in atopic and nonatopic bronchial asthma Yutaro Shiota, MD, PhDa, Hitomi Arikita, MTa, Naokatsu Horita, MDb,

Emma Broadfield, MRCP, Tricia M

The role and remediation of animal allergens in allergic diseases

Martin Brasholt, MD, Florent Baty, PhD, Hans Bisgaard, MD, DMSci

Preparing patients and health professionals for the transition to chlorofluorocarbon-free inhalers: The British perspective Helen Donohoe, MSc (Econ)

Practice Notes from the AAAI

Induced sputum: Validity of fluid-phase IL-5 measurement

Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonide Ensio Norjavaara, MD, PhDa,b, Maria Gerhardsson.

Abnormalities of cell and mediator levels in bronchoalveolar lavage fluid of patients with mild asthma Sally E. Wenzel, MD Journal of Allergy and Clinical.

Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy Diane J. Pincus, MD, Teresa R. Humeston,

Footnotes1 Journal of Allergy and Clinical Immunology

National trends in asthma visits and asthma pharmacotherapy,

Macrolide antibiotics and asthma treatment

Exhaled carbon monoxide levels after a course of oral prednisone in children with asthma exacerbation Stefania Zanconato, MD, PhD, Massimo Scollo, MD,

Evelyn Farinas, RPh, MGA, Peter Honig, MD

The environmental predictors of allergic disease

Pioneers and milestones

Bruce K. Bacot, MD, Mary E. Paul, MD, Maritza Navarro, MD, Stuart L

Exposure and sensitization to environmental allergen of predominantly Hispanic children with asthma in San Diego’s inner city Sandra C. Christiansen,

News & Notes Journal of Allergy and Clinical Immunology

Natural history of cow’s milk allergy

Presentation transcript:

Direct and indirect costs of asthma to an employer Howard G. Birnbaum, PhDa, William E. Berger, MD, MBAb, Paul E. Greenberg, MS, MAa, Michael Holland, BAa, Rebecca Auerbach, MSc, Kelly M. Atkins, PharmDd, Lee A. Wanke, RPh, MS, FASHPd Journal of Allergy and Clinical Immunology Volume 109, Issue 2, Pages 264-270 (February 2002) DOI: 10.1067/mai.2002.121310 Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 1 1998 Medical claims per treated asthmatic patient by type of service. Average refers to the mean of the observations. SDs for total claims: A , 19.9 (23.3) 6.9 (12.3); C , 20.4 (23.4) 10.2 (13.8). Medical care does not include prescription drug claims. *Differences between asthmatic sample and control sample for A-C : P < .0001. P values were derived with t tests. **Other includes care at patient's home, nursing-extended care facility, substance abuse treatment facility, independent clinical laboratories, freestanding dialysis facility, or durable medical equipment visits. Journal of Allergy and Clinical Immunology 2002 109, 264-270DOI: (10.1067/mai.2002.121310) Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 2 1998 Employer payments for treated asthmatic patients: health care, prescription drug, disability, and absenteeism. SDs: patient sample, see Table II; employee sample, 8687 (10,415) 4249 (8089); disability claimants, 14,827 (12,112) 5280 (9204). Differences between asthmatic patients and control subjects (for all samples): P < .0001. P values were derived with t tests. *Pharmacy costs associated with direct asthma care include secondary asthma-related prescriptions, which are also used for the treatment of other respiratory diseases. Journal of Allergy and Clinical Immunology 2002 109, 264-270DOI: (10.1067/mai.2002.121310) Copyright © 2002 Mosby, Inc. Terms and Conditions